This morning, Johnson & Johnson shared its 2023 fourth-quarter and full-year earnings report.
Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 130,000 employees across the globe working every day to help change the trajectory of health for humanity.
“Johnson & Johnson delivered strong results in 2023 while we continued to invest in advancing and strengthening our pipeline,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Our diverse portfolio offers innovative solutions from both our Innovative Medicine and MedTech businesses and, coupled with a multifaceted approach to capital allocation, provides the foundation for us to further improve health outcomes for patients and deliver significant value to shareholders.”
For more details about the company’s 2023 fourth-quarter and full-year results, and to read a message from Chairman and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.
Johnson & Johnson’s 2024 Earnings
Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.
